NCT06626919 2026-02-25A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related DiseasesArcellx, Inc.Phase 1 Recruiting30 enrolled
NCT00954746 2015-06-16Longterm Observational Study in Subjects Treated With AA4500 in AUX-CC-854, 856, 857, 858 & 859Endo PharmaceuticalsCompleted645 enrolled